Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel tachykinin NK1 antagonists designed at Merck

Oct. 28, 2004

New NY-ESO-1-derived peptide and its use reported in a recent patent

Oct. 28, 2004

Bayer presents new Raf kinase inhibitors with potential utility in cancer therapy

Oct. 28, 2004

New 5-HT2C receptor modulators under study at GSK

Oct. 27, 2004

Roche claims new 5-HT6 receptor ligands for cognitive disorders, psychosis, etc.

Oct. 27, 2004

Urea-based glycogen phosphorylase a inhibitors newly developed at Aventis

Oct. 27, 2004

Novel MCH receptor antagonists prepared and tested at Schering-Plough

Oct. 27, 2004

Agents combining antimitotic, antiangiogenic and PDE4 activity claimed by Celgene

Oct. 27, 2004

New Eg5 kinesin inhibitors developed by AstraZeneca researchers

Oct. 27, 2004

Novel JNK inhibitors and their use reported by Eisai

Oct. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...